Estimated read time 2 min read

South Korean pharma giant, Celltrion, initiates share cancellation to enhance value

South Korean pharmaceutical giant Celltrion Inc. has announced its decision to cancel approximately 1 percent of its outstanding shares, a move aimed at bolstering shareholder [more…]

Estimated read time 3 min read

South Korean companies face profitability crunch amid economic challenges

In the face of a challenging economic environment, South Korean companies experienced a decline in sales growth and a narrowing of profitability in the third [more…]

Estimated read time 2 min read

South Korean stocks face headwinds amid U.S. government shutdown concerns and Moody’s rating cut

South Korean stocks experienced a downward trend on Monday, fueled by growing concerns over a potential US government shutdown following a downgrade in Moody’s rating [more…]

Estimated read time 3 min read

Coupang shares slides overshadowing its record Q3 earnings and growing customer base

In a recent announcement, South Korean e-commerce giant Coupang has continued its impressive financial winning streak by revealing record third-quarter earnings. These outstanding results are [more…]